Home Authors Posts by William H. Bestermann, Jr., MD

William H. Bestermann, Jr., MD

William H. Bestermann, Jr., MD
William H. Bestermann Jr., MD is a board-certified internist who practiced preventive cardiology for 20 years. He has been heavily involved with health care reform and quality improvement during that same period. He wrote the first article on a systematic approach to the metabolic syndrome. He led an advanced cardiometabolic medical home that managed high-risk diabetic and hypertensive patients for a Fortune 100 company in Tennessee. He is a Senior Clinical Advisor for the Quality Blue Primary Care program at Blue Cross Blue Shield of Louisiana. That initiative saved $27 pmpm net at the 18 month mark while reducing hospitalizations, length of stay, and specialty referrals. He is currently the Chief Medical Officer at Epigenex Health Inc.
The word VOTE in red, white, and blue 1000 x 705

An Election Day Reminder: Vote Like Your Life Depends On It

Politicians are fanning the dark side in America giving rise to entrenched divisions. But pulling away to our corners while insulting, demonizing, and dehumanizing people who look or think differently is a formula for national disaster.
Man with severely sun damaged skin 1280 x 742

A Unifying Hypothesis of Chronic Disease and Aging

Accelerated aging and disease in the skin are largely driven by excess oxidative particles generated by sun exposure and other environmental factors.
Doctor showing business man info on tablet 1280 x 851

How to Achieve High Value from your Executive Health Program

Executive health programs often include interventions that are high cost, low efficacy or both including screening tests offer no value & may even cause harm.

Why We Need to Unlock the Full Potential of Primary Care

Primary care 3.0 focuses on molecular medical management that prevents & effectively treats chronic conditions & slows aging. Everyone should have access to it.

The ACCORD Trial: Is Aggressive Glucose Lowering Finished?

Glucose lowering, per se, does not prevent heart attack, stroke, or death. The message to take away from the ACCORD shut-down is that aggressive treatment is a bad idea.

New Technology to Determine Risk of Heart Attack

Dr. Bestermann explains the extensive literature on the new science of risk assessment and the importance of vulnerable plaque.
heart attack

Sudden Death: When Will We Finally Do What Needs to be Done?

In 1988, Dr. WC Little wrote that bypass surgery and angioplasty could not be expected to prevent heart attack in stable patients. He predicted the results of the landmark COURAGE trial 20 years ahead of time.

Type 2 Diabetes Treatment Made Easy

Most type 2 diabetics have been resistant to the effects of insulin and metabolically abnormal for years prior to developing full-blown diabetes.
doctor talking to patient (448 x 299)

If You Want to Get It Up, You Have to Get It Down!

Remember the ruggedly handsome, cool cowboy on the cigarette commercial? Smoke a cigarette and you can be like him! Well, there's one reason you don't want to be like him. He is a prime candidate for erectile dysfunction.

The Cardiometabolic Syndrome is a Complex Metabolic Web

The underpinning for much of the death and disability from arterial vascular disease in this country is the metabolic syndrome.
living with Crohn's disease (1000 x 652)

How to Get the Best Care for Type 2 Diabetes

If you have type 2 diabetes, it is important that you educate yourself so that you can be confident that you are receiving the care that you should have.

What Medicine Can Learn From Progress in Military Strategy

If we simply applied what we have already learned in medicine, we could eliminate enormous suffering and significantly reduce the cost of these conditions.